UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Current role of radiation therapy for multiple myeloma

Frontiers in oncology, 2015-02, Vol.5, p.40-40

2015

Volltextzugriff (PDF)

Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia

Clinical lymphoma, myeloma and leukemia, 2015-01, Vol.15 (1), p.41-46

2015

Volltextzugriff (PDF)

Gaps in pre-rituximab hepatitis B screening: an institutional experience

American journal of therapeutics, 2015-11, Vol.22 (6), p.456

2015

Volltextzugriff (PDF)

Guillain–Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

Leukemia research, 2010-07, Vol.34 (7), p.e154-e156

2010

Volltextzugriff (PDF)

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34 + selected graft

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1632-1634

2020

Volltextzugriff (PDF)

Pulmonary collision tumor consisting of adenocarcinoma and typical carcinoid--a case report and review of literature

American journal of therapeutics, 2014-11, Vol.21 (6), p.e234

2014

Volltextzugriff (PDF)

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

OncoTargets and therapy, 2017-01, Vol.10, p.217-226

2017

Volltextzugriff (PDF)

Current approaches to epigenetic therapy for the treatment of mantle cell lymphoma

Advances in experimental medicine and biology, 2013, Vol.779, p.257

2013

Volltextzugriff (PDF)

Primary CNS lymphoplasmacytic lymphoma: A case report and review of literature

Hematology/oncology and stem cell therapy, 2013-06, Vol.6 (2), p.76-78

2013

Volltextzugriff (PDF)

Marginal zone lymphoma: old, new, targeted, and epigenetic therapies

Therapeutic Advances in Hematology, 2012-10, Vol.3 (5), p.275-290

2012

Volltextzugriff (PDF)

Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma

Biology of blood and marrow transplantation, 2015-03, Vol.21 (3), p.468-472

2015

Volltextzugriff (PDF)

Leptomeningeal carcinomatosis as the only manifestation of disease in recurrent gastroesophageal cancers

Gastrointestinal cancer research, 2011-03, Vol.4 (2), p.68-71

2011

Volltextzugriff (PDF)

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34.sup.+ selected graft

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1632

2020

Volltextzugriff (PDF)

Potential Pitfalls of Serum Free Light Chain Analysis to Assess Treatment Response for Multiple Myeloma

Blood, 2015-12, Vol.126 (23), p.5308-5308

2015

Volltextzugriff (PDF)

Collection of Peripheral Blood Stem Cells in Patients with Multiple Myeloma after Stem Cell Transplant: A Single Institution Experience

Blood, 2015-12, Vol.126 (23), p.5435-5435

2015

Volltextzugriff (PDF)

Salvage Tandem Autologous Stem Cell Transplant with Consolidation for Relapsed Multiple Myeloma

Blood, 2015-12, Vol.126 (23), p.5497-5497

2015

Volltextzugriff (PDF)

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma

British journal of haematology, 2016-08, Vol.174 (4), p.536-540

2016

Volltextzugriff (PDF)

Non-Biologic Factors and Outcomes in Allogeneic Stem Cell Transplant

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S193-S193

2016

Volltextzugriff (PDF)

Cytomegalovirus and Human Herpes Virus-6 Reactivation Following Tandem Transplantation Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma (MM)

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S177-S178

2016

Volltextzugriff (PDF)

Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S358-S358

2016

Volltextzugriff (PDF)

Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease

American journal of therapeutics, 2015-01, Vol.22 (1), p.e6

2015

Volltextzugriff (PDF)

Combination HDACi and mTOR inhibitor therapy in poor-risk de novo and refractory elderly patients with AML

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e18012-e18012

2013

Volltextzugriff (PDF)

Cost-benefit of recurrence score–guided treatment using an Onco type DX 21-gene assay: A single institution analysis

Journal of clinical oncology, 2013-09, Vol.31 (26_suppl), p.29-29

2013

Volltextzugriff (PDF)

Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma

Leukemia & lymphoma, 2011-08, Vol.52 (8), p.1488-1494

2011

Volltextzugriff (PDF)

Bortezomib, Dexamethasone, Thalidomide and Melphalan (VDT-Mel) Preparative Regimen in Autologous Stem Cell Transplant (ASCT) Results in a Very High Stringent CR (sCR) Rate in Multiple Myeloma (MM)

Blood, 2015-12, Vol.126 (23), p.1971-1971

2015

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(37)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(10)
Hematology, Oncology And Palliative Medicine
(9)
Female
(8)
Aged
(7)
Hematology
(7)
Oncology
(7)
Male
(6)
Middle Aged
(6)
Adult
(4)
Multiple Myeloma
(4)
Retrospective Studies
(4)
Pharmacology & Pharmacy
(3)
Stem Cells
(3)
Transplantation
(3)
Treatment Outcome
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cladribine
(2)
Dna Methylation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current role of radiation therapy for multiple myeloma

Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia

Gaps in pre-rituximab hepatitis B screening: an institutional experience

Guillain–Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34 + selected graft

Pulmonary collision tumor consisting of adenocarcinoma and typical carcinoid--a case report and review of literature

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Current approaches to epigenetic therapy for the treatment of mantle cell lymphoma

Primary CNS lymphoplasmacytic lymphoma: A case report and review of literature

Marginal zone lymphoma: old, new, targeted, and epigenetic therapies

Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma

Leptomeningeal carcinomatosis as the only manifestation of disease in recurrent gastroesophageal cancers

Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34.sup.+ selected graft

Potential Pitfalls of Serum Free Light Chain Analysis to Assess Treatment Response for Multiple Myeloma

Collection of Peripheral Blood Stem Cells in Patients with Multiple Myeloma after Stem Cell Transplant: A Single Institution Experience

Salvage Tandem Autologous Stem Cell Transplant with Consolidation for Relapsed Multiple Myeloma

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma

Non-Biologic Factors and Outcomes in Allogeneic Stem Cell Transplant

Cytomegalovirus and Human Herpes Virus-6 Reactivation Following Tandem Transplantation Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma (MM)

Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience

Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease

Combination HDACi and mTOR inhibitor therapy in poor-risk de novo and refractory elderly patients with AML

Cost-benefit of recurrence score–guided treatment using an Onco type DX 21-gene assay: A single institution analysis

Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma

Bortezomib, Dexamethasone, Thalidomide and Melphalan (VDT-Mel) Preparative Regimen in Autologous Stem Cell Transplant (ASCT) Results in a Very High Stringent CR (sCR) Rate in Multiple Myeloma (MM)

Suchergebnisse filtern